American Bio Medica Corp (ABMC) financial statements (2020 and earlier)

Company profile

Business Address 122 SMITH ROAD
KINDERHOOK, NY 12106
State of Incorp. NY
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1511336156158352646
Cash and cash equivalents1511336156158352646
Receivables492452348556672814875
Inventory, net of allowances, customer advances and progress billings8901,0191,4731,5821,7461,7222,071
Inventory8901,0191,4731,5821,7461,7222,071
Deferred costs     4351
Other undisclosed current assets36299792408596
Total current assets:1,4331,6131,9542,3862,6163,0163,739
Noncurrent Assets
Operating lease, right-of-use asset11
Property, plant and equipment6637187928249109831,090
Intangible assets, net (including goodwill)118123109936765
Intangible assets, net (excluding goodwill)118123109936765 
Regulated entity, other noncurrent assets      80
Deferred costs    190  
Other noncurrent assets21212121141414
Other undisclosed noncurrent assets  1547  43
Total noncurrent assets:8138629379851,1811,0621,227
TOTAL ASSETS:2,2462,4752,8913,3713,7974,0784,966
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities742840808713740772856
Accounts payable606359374304373410597
Accrued liabilities 757525255126
Employee-related liabilities136278259299292264233
Taxes payable 11589673721 
Interest and dividends payable 1311181326 
Debt1,5227395337148521,8371,226
Deferred compensation liability 167113    
Other liabilities 201293663975
Other undisclosed current liabilities53459117371551,200
Total current liabilities:2,7981,8251,4771,5931,7292,7033,357
Noncurrent Liabilities
Long-term debt and lease obligation11  75394521360
Long-term debt, excluding current maturities   75394521360
Operating lease, liability11
Liabilities, other than long-term debt 719 162192147
Due to related parties    124124 
Other liabilities 719 3868147
Other undisclosed noncurrent liabilities 789772   64
Total noncurrent liabilities:117967917531,107405271
Total liabilities:2,8092,6212,2682,3462,8363,1083,628
Stockholders' equity
Stockholders' equity attributable to parent, including:(563)(146)6231,0259619701,338
Common stock325323298288260236229
Additional paid in capital21,42521,40421,17021,03720,65620,35620,241
Accumulated deficit(22,313)(21,873)(20,845)(20,300)(19,955)(19,622)(19,132)
Warrants and rights outstanding      3,303
Other undisclosed stockholders' equity attributable to parent      (3,303)
Total stockholders' equity:(563)(146)6231,0259619701,338
TOTAL LIABILITIES AND EQUITY:2,2462,4752,8913,3713,7974,0784,966

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues3,6603,8724,9145,6096,3177,2858,894
Revenue, net4,9145,6096,3177,2858,894
Cost of revenue(2,574)(2,584)(2,917)(3,119)(3,462)(4,223)(5,322)
Cost of goods and services sold  (2,917)(3,119)(3,462)(4,223)(5,322)
Gross profit:1,0861,2881,9972,4902,8553,0623,572
Operating expenses(1,845)(2,050)(2,308)(2,747)(3,081)(3,320)(4,972)
Other undisclosed operating income     41269
Operating loss:(759)(762)(311)(257)(226)(217)(1,131)
Nonoperating income (expense)(92)(264)(234)(84)10114653
Other nonoperating income (expense)(92)(264)(234)(84)10214 
Interest and debt expense(267)(284)(272)(284)(206)(244)(310)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes267284272284 (41)2
Loss from continuing operations before income taxes:(851)(1,026)(545)(341)(331)(488)(786)
Income tax expense(2)(2) (4)(2)(2)(2)
Net loss available to common stockholders, diluted:(853)(1,028)(545)(345)(333)(490)(788)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(853)(1,028)(545)(345)(333)(490)(788)
Comprehensive loss, net of tax, attributable to parent:(853)(1,028)(545)(345)(333)(490)(788)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: